Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly

Hepatology

Volumn 43, Issue 3, 2006, Pages 532-538

  Czaja, Albert J ^a   Carpenter, Herschel A ^b  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; PREDNISONE;

ADULT; AGE; AGE DISTRIBUTION; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; AUTOIMMUNE HEPATITIS TYPE 1; DRUG TREATMENT FAILURE; FEMALE; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RHEUMATIC DISEASE; RISK FACTOR; THYROID DISEASE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS, AUTOIMMUNE; HLA-DR3 ANTIGEN; HLA-DR4 ANTIGEN; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33645219865     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21074     Document Type: Article

References (46)

1. Bongiovanni AM, Eisenmenger WJ. Adrenal cortical metabolism in chronic liver disease. J Clin Endocrinol 1951;11:152-172.
2. Bearn AG, Kunkel HG, Slater RJ. The problem of chronic liver disease in young women. Am J Med 1956;21:3-15.
3. Mackay JR, Taft LI, Cowling DC. Lupoid hepatitis. Lancet 1956;2:1323-1326.
4. Bartholomew LG, Hagedorn AB, Cain JC, Baggenstoss AH. Hepatitis and cirrhosis in women with positive clot tests for lupus erythematosus. N Engl J Med 1958;259:947-56.
5. Willocx RG, Isselbacher KJ. Chronic liver disease in young people. Clinical features and course of thirty-three patients. Am J Med 1961;30:185-195.
6. Read AE, Sherlock S, Harrison CV. Active "juvenile" cirrhosis considered as part of a systemic disease and the effect of corticosteroid therapy. Gut 1963;4:378-393.
7. Keating JJ, O'Brien CJ, Stellon AJ, Portmann BC, Johnson RD, Johnson PJ, et al. Influence of aetiology, clinical, and histological features on survival in chronic active hepatitis: an analysis of 204 patients. QJM 1987;62:59-66.
8. McFarlane IG. The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis. Gut 1998;42:599-602.
9. McFarlane IG. Autoimmune hepatitis: clinical manifestations and diagnostic criteria. Can J Gastroenterol 2001;15:107-113.
10. McFarlane IG. Autoimmune hepatitis: diagnostic criteria, subclassifications, and clinical features. Clin Liver Dis 2002;6:605-621.
11. Parker DR, Kingham JGC. Type 1 autoimmune hepatitis is primarily a disease of later life. QJM 1997;90:289-296.
12. Newton JL, Burt AD, Park JB, Mathew J, Bassendine MF, James OFW. Autoimmune hepatitis in older patients. Age Ageing 1997;26:441-444.
13. Schramm C, Kanzler S, Meyer zum Buschenfelde K-H, Galle PR, Lohse AW. Autoimmune hepatitis in the elderly. Am J Gastroenterol 2001;96:1587-1591.
14. Lebovics E, Schaffner F, Klion EM, Simon C. Autoimmune chronic active hepatitis in postmenopausal women. Dig Dis Sci 1985;30:824-828.
15. Wang KK, Czaja AJ. Prognosis of corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis in postmenopausal women: a retrospective analysis. Gastroenterology 1989;97:1288-1293.
16. Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. HEPATOLOGY 1991;13:701-706.
17. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Significance of HLA DR4 in type 1 autoimmune hepatitis. Gastroenterology 1993;105:1502-1507.
18. Czaja AJ, Strettell MDJ, Thomson LJ, Santrach PJ, Moore SB, Donaldson PT, et al. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. HEPATOLOGY 1997;25:317-323.
19. Seki T, Kiyosawa K, Inoko H, Ota M. Association of autoimmune hepatitis with HLA-Bw54 and DR4 in Japanese patients. HEPATOLOGY 1990;12:1300-1304.
20. Seki T, Ota M, Furuta S, Fukushima H, Kondo T, Hino K, et al. HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology 1992;103:1041-1047.
21. Fainboim L, Velasco VCC, Marcos CY, Ciocca M, Roy A, Theiler G, et al. Protracted, but not acute, hepatitis A virus infection is strongly associated with HLA-DRB1*1301, a marker for pediatrie autoimmune hepatitis. HEPATOLOGY 2001;33:1512-1517.
22. Donaldson PT, Czaja AJ. Genetic effects on susceptibility, clinical expression, and treatment outcome of type 1 autoimmune hepatitis. Clin Liver Dis 2002;6:707-725.
23. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. HEPATOLOGY 2002;36:479-497.
24. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-938.
25. Czaja AJ, Norman GL. Autoantibodies in the diagnosis and management of liver disease. J Clin Gastroenterol 2003;37:315-329.
26. Czaja AJ, Manns MP. The validity and importance of subtypes of autoimmune hepatitis: a point of view. Am J Gastroenterol 1995;90:1206-1211.
27. Czaja AJ, Carpenter HA. Sensitivity, specificity and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology 1993;105:1824-1832.
28. Summerskill WHJ, Korman MG, Ammon HV, Baggenstoss AH. Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. Gut 1975;16:876-883.
29. Czaja AJ. Treatment strategies in autoimmune hepatitis. Clin Liver Dis 2002;6:799-824.
30. Czaja AJ, Rakela J, Ludwig J. Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis. Gastroenterology 1988;95:448-453.
31. Czaja AJ, Carpenter HA. Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis. HEPATOLOGY 2004;39:1631-1638.
32. Nikias GA, Batts KP, Czaja AJ. The nature and prognostic implications of autoimmune hepatitis with an acute presentation. J Hepatol 1994;21:866-871.
33. Czaja AJ, Doherty DG, Donaldson PT. Genetic bases of autoimmune hepatitis. Dig Dis Sci 2002;47:2139-2150.
34. Doherty DG, Donaldson PT, Underhill JA, Farrant JM, Duthie A, Mieli-Vergani G, et al. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. HEPATOLOGY 1994;19:609-615.
35. Schreuder GM, Hurley CK, Marsh SG, Lau M, Maiers M, Kollman C, et al. The HLA dictionary 2001: a summary of HLA-A, -B, -C, DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. Hum Immunol 2001;62:826-849.
36. Czaja AJ, Donaldson PT. Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis. Am J Gastroenterol 2002;97:2051-2057.
37. Davis GL, Czaja AJ, Ludwig J. Development and prognosis of histologic cirrhosis in corticosteroid-treated HBsAg-negative chronic active hepatitis. Gastroenterology 1984;87:1222-1227.
38. Roberts SK, Therneau T, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology 1996;110:848-857.
39. Schalm SW, Ammon HV, Summerskill WHJ. Failure of customary treatment in chronic active liver disease: causes and management. Ann Clin Res 1976;8:221-227.
40. Brattsand R, Linden M. Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Aliment Pharmacol Ther 1996;10(Suppl 2):81-90.
41. Almawi WY. Molecular mechanisms of glucocorticoid effects. Mod Aspects Immunobiol 2001;2:78-82.
42. Villanueva JL, Solana R, Alonso MC, Pena J. Changes in the expression of HLA class II antigens on peripheral blood monocytes from aged humans. Dis Markers 1990;8:85-91.
43. Murasko DM, Goonewardene IM. T cell function in aging: mechanisms of decline. Ann Rev Gerontol Geriatr 1990;10:71-96.
44. Currie MS. Immunosenescence. Comprehensive Therapy 1992;18:26-34.
45. Talor E, Rose NR. Hypothesis: the aging paradox and autoimmune disease. Autoimmunity 1991;8:245-249.
46. Czaja AJ. Understanding the pathogenesis of autoimmune hepatitis. Am J Gastroenterol 2001;96:1224-1231.